Affiliation:
1. Peking University People's Hospital
Abstract
Abstract
Introduction
An increasing number of young patients with early-stage endometrial cancer are opting for fertility-sparing treatment, and they have achieved reassuring rates of complete remission, with some women achieving pregnancy. However, surgical treatment is still recommended for patients with advanced endometrial cancer. We reported a woman with IVb endometrial cancer (EC) who reached complete remission (CR) and gained a live birth successfully with the help of in vitro fertilization and embryo transfer (IVF-ET).
Case report
A 30-year-old woman found to have stage IVb EC after hysteroscopy, laparoscopy, and pathological examination. After a combination of chemotherapy and progesterone therapy, the woman achieved complete remission. The woman became pregnant with IVF-ET and got a full-term live birth. In addition, there was no recurrence after 19 months of observation. The molecular classification of POLE and the combination of chemotherapy and progesterone therapy may be associated with a good prognosis of this patient. The use of progestin-primed ovarian stimulation (PPOS) and the combination of letrozole and levonorgestrel-releasing intrauterine device (LNG-IUD) during ovulation induction seemed to be safe for the woman
Conclusion
This is the first report on fertility-sparing treatment and live birth for advanced EC. IVF-ET is feasible for women with EC who preserve reproductive function. The progestin-primed ovarian stimulation combined with levonorgestrel-releasing intrauterine device and letrozole seems to be safe for these women. Patients still need to be closely watched for tumor recurrence.
Publisher
Research Square Platform LLC
Reference28 articles.
1. Fertility-sparing management for endometrial cancer: review of the literature;Garzon S;Minerva Med,2021
2. National Comprehensive Cancer Network. (NCCN) Clinical Practice Guidelines in Oncology. Endometrial Carcinoma, Version 1. 2022. https://www.nccn.org/login?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf. Accessed 15 Sept 2022. In.
3. Xiao Z, Song Z, et al. Pregnancy outcomes after fertility preservation in women with endometrial carcinoma and atypical endometrial hyperplasia: A systematic review and meta-analysis. Gynecology and Obstetrics Clinical Medicine; 2021.
4. Cicinelli E, Tinelli R et al. Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study. Menopause. 2010 May-Jun;17(3):511-5. 10.1097/gme.0b013e3181c8534d. PMID: 20081548.
5. Whether preoperative hysteroscopy increases the dissemination of endometrial cancer cells: A systematic review and meta-analysis;Dong H;J Obstet Gynaecol Res,2021